H. R. 266 
One Hundred Sixteenth Congress 
of the 
United States of America 
AT THE SECOND SESSION 
Begun and held at the City of Washington on Friday, 
the third day of January, two thousand and twenty 
An Act 
Making appropriations for the Department of the Interior, environment, and related 
agencies for the fiscal year ending September 30, 2019, and for other purposes. 
Be it enacted by the Senate and House of Representatives of 
the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Paycheck Protection Program 
and Health Care Enhancement Act’’. 
SEC. 2. TABLE OF CONTENTS. 
The table of contents for this Act is as follows: 
Sec. 1. Short title. 
Sec. 2. Table of contents. 
Sec. 3. References. 
DIVISION A—SMALL BUSINESS PROGRAMS 
Sec. 101. Amendments to the Paycheck Protection Program, economic injury dis-
aster loans, and emergency grants. 
Sec. 102. Emergency designation. 
DIVISION B—ADDITIONAL EMERGENCY APPROPRIATIONS FOR 
CORONAVIRUS RESPONSE 
SEC. 3. REFERENCES. 
Except as expressly provided otherwise, any reference to ‘‘this 
Act’’ contained in any division of this Act shall be treated as 
referring only to the provisions of that division. 
DIVISION A—SMALL BUSINESS 
PROGRAMS 
SEC. 101. AMENDMENTS TO THE PAYCHECK PROTECTION PROGRAM, 
ECONOMIC INJURY DISASTER LOANS, AND EMERGENCY 
GRANTS. 
(a) INCREASED AUTHORITY FOR COMMITMENTS AND APPROPRIA-
TIONS FOR PAYCHECK PROTECTION PROGRAM.—Title I of division 
A of the Coronavirus Aid, Relief, and Economic Security Act (Public 
Law 116–136) is amended— 
(1) in section 1102(b)(1), by striking ‘‘$349,000,000,000’’ 
and inserting ‘‘$659,000,000,000’’; and 
(2) in section 1107(a)(1), by striking ‘‘$349,000,000,000’’ 
and inserting ‘‘$670,335,000,000’’. 
(b) 
INCREASED
AUTHORIZATION
FOR
EMERGENCY
EIDL 
GRANTS.—Section 1110(e)(7) of division A of the Coronavirus Aid,
H. R. 266—2 
Relief, and Economic Security Act (Public Law 116–136) is amended 
by striking ‘‘$10,000,000,000’’ and inserting ‘‘$20,000,000,000’’. 
(c) ELIGIBILITY OF AGRICULTURAL ENTERPRISES FOR ECONOMIC 
INJURY
DISASTER
LOANS
AND
EMERGENCY
GRANTS.—Section 
1110(a)(2) of division A of the Coronavirus Aid, Relief, and Economic 
Security Act (Public Law 116–136) is amended— 
(1) in subparagraph (D), by striking ‘‘or’’ at the end; 
(2) in subparagraph (E), by striking the period at the 
end and inserting ‘‘; or’’; and 
(3) by adding at the end the following: 
‘‘(F) an agricultural enterprise (as defined in section 
18(b) of the Small Business Act (15 U.S.C. 647(b)) with 
not more than 500 employees.’’. 
(d) SET ASIDE FOR INSURED DEPOSITORY INSTITUTIONS, CREDIT 
UNIONS, 
AND
COMMUNITY
FINANCIAL
INSTITUTIONS.—Section 
7(a)(36) of the Small Business Act (15 U.S.C. 636(a)(36)) is 
amended— 
(1) in subparagraph (A)— 
(A) in clause (viii), by striking ‘‘and’’ at the end; 
(B) in clause (ix), by striking the period at the end 
and inserting a semicolon; and 
(C) by adding at the end the following: 
‘‘(x) the term ‘community development financial 
institution’ has the meaning given the term in section 
103 of the Riegle Community Development and Regu-
latory Improvement Act of 1994 (12 U.S.C. 4702)); 
‘‘(xi) the term ‘community financial institutions’ 
means— 
‘‘(I) 
a 
community 
development 
financial 
institution; 
‘‘(II) a minority depository institution, as 
defined in section 308 of the Financial Institutions 
Reform, Recovery, and Enforcement Act of 1989 
(12 U.S.C. 1463 note); 
‘‘(III) a development company that is certified 
under title V of the Small Business Investment 
Act of 1958 (15 U.S.C. 695 et seq.); and 
‘‘(IV) an intermediary, as defined in section 
7(m)(11); and 
‘‘(xii) the term ‘credit union’ means a State credit 
union or a Federal credit union, as those terms are 
defined, respectively, in section 101 of the Federal 
Credit Union Act (12 U.S.C. 1752).’’; and 
(2) by adding at the end the following: 
‘‘(S) SET-ASIDE FOR INSURED DEPOSITORY INSTITUTIONS, 
CREDIT UNIONS, AND COMMUNITY FINANCIAL INSTITUTIONS.— 
‘‘(i) INSURED DEPOSITORY INSTITUTIONS AND CREDIT 
UNIONS.—In making loan guarantees under this para-
graph after the date of enactment of this clause, the 
Administrator 
shall 
guarantee 
not 
less 
than 
$30,000,000,000 in loans made by— 
‘‘(I) 
insured 
depository 
institutions 
with 
consolidated 
assets 
of 
not 
less 
than 
$10,000,000,000 and less than $50,000,000,000; 
and
H. R. 266—3 
‘‘(II) credit unions with consolidated assets of 
not less than $10,000,000,000 and less than 
$50,000,000,000. 
‘‘(ii) COMMUNITY FINANCIAL INSTITUTIONS, SMALL 
INSURED
DEPOSITORY
INSTITUTIONS, 
AND
CREDIT 
UNIONS.—In making loan guarantees under this para-
graph after the date of enactment of this clause, the 
Administrator 
shall 
guarantee 
not 
less 
than 
$30,000,000,000 in loans made by— 
‘‘(I) community financial institutions; 
‘‘(II) insured depository institutions with 
consolidated assets of less than $10,000,000,000; 
and 
‘‘(III) credit unions with consolidated assets 
of less than $10,000,000,000.’’. 
SEC. 102. EMERGENCY DESIGNATION. 
(a) IN GENERAL.—The amounts provided under this division 
are designated as an emergency requirement pursuant to section 
4(g) of the Statutory Pay-As-You-Go Act of 2010 (2 U.S.C. 933(g)). 
(b) DESIGNATION IN SENATE.—In the Senate, this division is 
designated as an emergency requirement pursuant to section 
4112(a) of H. Con. Res. 71 (115th Congress), the concurrent resolu-
tion on the budget for fiscal year 2018. 
DIVISION B—ADDITIONAL EMERGENCY 
APPROPRIATIONS FOR CORONAVIRUS RESPONSE 
The following sums are hereby appropriated, out of any money 
in the Treasury not otherwise appropriated, for the fiscal year 
ending September 30, 2020, and for other purposes, namely: 
TITLE I 
DEPARTMENT OF HEALTH AND HUMAN SERVICES 
OFFICE OF THE SECRETARY 
PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND 
(INCLUDING TRANSFER OF FUNDS) 
For an additional amount for ‘‘Public Health and Social Services 
Emergency Fund’’, $75,000,000,000, to remain available until 
expended, to prevent, prepare for, and respond to coronavirus, 
domestically or internationally, for necessary expenses to reimburse, 
through grants or other mechanisms, eligible health care providers 
for health care related expenses or lost revenues that are attrib-
utable to coronavirus: Provided, That these funds may not be used 
to reimburse expenses or losses that have been reimbursed from 
other sources or that other sources are obligated to reimburse: 
Provided further, That recipients of payments under this paragraph 
in this Act shall submit reports and maintain documentation as 
the Secretary of Health and Human Services (referred to in this 
paragraph as the ‘‘Secretary’’) determines are needed to ensure 
compliance with conditions that are imposed by this paragraph 
in this Act for such payments, and such reports and documentation 
shall be in such form, with such content, and in such time as
H. R. 266—4 
the Secretary may prescribe for such purpose: Provided further, 
That ‘‘eligible health care providers’’ means public entities, Medicare 
or Medicaid enrolled suppliers and providers, and such for-profit 
entities and not-for-profit entities not otherwise described in this 
proviso as the Secretary may specify, within the United States 
(including territories), that provide diagnoses, testing, or care for 
individuals with possible or actual cases of COVID–19: Provided 
further, That the Secretary shall, on a rolling basis, review applica-
tions and make payments under this paragraph in this Act: Pro-
vided further, That funds appropriated under this paragraph in 
this Act shall be available for building or construction of temporary 
structures, leasing of properties, medical supplies and equipment 
including personal protective equipment and testing supplies, 
increased workforce and trainings, emergency operation centers, 
retrofitting facilities, and surge capacity: Provided further, That, 
in this paragraph, the term ‘‘payment’’ means a pre-payment, 
prospective payment, or retrospective payment, as determined 
appropriate by the Secretary: Provided further, That payments 
under this paragraph in this Act shall be made in consideration 
of the most efficient payment systems practicable to provide emer-
gency payment: Provided further, That to be eligible for a payment 
under this paragraph in this Act, an eligible health care provider 
shall submit to the Secretary an application that includes a state-
ment justifying the need of the provider for the payment and 
the eligible health care provider shall have a valid tax identification 
number: Provided further, That, not later than 3 years after final 
payments are made under this paragraph in this Act, the Office 
of Inspector General of the Department of Health and Human 
Services shall transmit a final report on audit findings with respect 
to this program to the Committees on Appropriations of the House 
of Representatives and the Senate: Provided further, That nothing 
in this paragraph limits the authority of the Inspector General 
or the Comptroller General to conduct audits of interim payments 
at an earlier date: Provided further, That not later than 60 days 
after the date of enactment of this Act, the Secretary shall provide 
a report to the Committees on Appropriations of the House of 
Representatives and the Senate on obligation of funds, including 
obligations to such eligible health care providers summarized by 
State of the payment receipt: Provided further, That such reports 
shall be updated and submitted to such Committees every 60 days 
until funds are expended: Provided further, That such amount 
is designated by the Congress as being for an emergency require-
ment pursuant to section 251(b)(2)(A)(i) of the Balanced Budget 
and Emergency Deficit Control Act of 1985. 
For an additional amount for ‘‘Public Health and Social Services 
Emergency Fund’’, $25,000,000,000, to remain available until 
expended, to prevent, prepare for, and respond to coronavirus, 
domestically or internationally, for necessary expenses to research, 
develop, validate, manufacture, purchase, administer, and expand 
capacity for COVID–19 tests to effectively monitor and suppress 
COVID–19, including tests for both active infection and prior expo-
sure, including molecular, antigen, and serological tests, the manu-
facturing, procurement and distribution of tests, testing equipment 
and testing supplies, including personal protective equipment 
needed for administering tests, the development and validation 
of rapid, molecular point-of-care tests, and other tests, support 
for workforce, epidemiology, to scale up academic, commercial,
H. R. 266—5 
public health, and hospital laboratories, to conduct surveillance 
and contact tracing, support development of COVID–19 testing 
plans, and other related activities related to COVID–19 testing: 
Provided, That of the amount appropriated under this paragraph 
in this Act, not less than $11,000,000,000 shall be for States, 
localities, territories, tribes, tribal organizations, urban Indian 
health organizations, or health service providers to tribes for nec-
essary expenses to develop, purchase, administer, process, and ana-
lyze COVID–19 tests, including support for workforce, epidemiology, 
use by employers or in other settings, scale up of testing by public 
health, academic, commercial, and hospital laboratories, and 
community-based testing sites, health care facilities, and other enti-
ties engaged in COVID–19 testing, conduct surveillance, trace con-
tacts, and other related activities related to COVID–19 testing: 
Provided further, That of the amount identified in the preceding 
proviso, not less than $2,000,000,000 shall be allocated to States, 
localities, and territories according to the formula that applied 
to the Public Health Emergency Preparedness cooperative agree-
ment in fiscal year 2019, not less than $4,250,000,000 shall be 
allocated to States, localities, and territories according to a formula 
methodology that is based on relative number of cases of COVID– 
19, and not less than $750,000,000 shall be allocated in coordination 
with the Director of the Indian Health Service, to tribes, tribal 
organizations, urban Indian health organizations, or health service 
providers to tribes: Provided further, That the Secretary of Health 
and Human Services (referred to in this paragraph as the ‘‘Sec-
retary’’) may satisfy the funding thresholds outlined in the first 
and second provisos under this paragraph in this Act by making 
awards through other grant or cooperative agreement mechanisms: 
Provided further, That not later than 30 days after the date of 
enactment of this Act, the Governor or designee of each State, 
locality, territory, tribe, or tribal organization receiving funds pursu-
ant to this Act shall submit to the Secretary its plan for COVID– 
19 testing, including goals for the remainder of calendar year 2020, 
to include: (1) the number of tests needed, month-by-month, to 
include diagnostic, serological, and other tests, as appropriate; (2) 
month-by-month estimates of laboratory and testing capacity, 
including related to workforce, equipment and supplies, and avail-
able tests; and (3) a description of how the State, locality, territory, 
tribe, or tribal organization will use its resources for testing, 
including as it relates to easing any COVID–19 community mitiga-
tion policies: Provided further, That the Secretary shall submit 
such formula methodology identified in the first proviso under this 
paragraph in this Act to the Committees on Appropriations of 
the House of Representatives and the Senate one day prior to 
awarding such funds: Provided further, That such funds identified 
in the first and second provisos under this paragraph in this Act 
shall be allocated within 30 days of the date of enactment of 
this Act: Provided further, That of the amount appropriated under 
this paragraph in this Act, not less than $1,000,000,000 shall be 
transferred to the ‘‘Centers for Disease Control and Prevention— 
CDC-Wide Activities and Program Support’’ for surveillance, epide-
miology, laboratory capacity expansion, contact tracing, public 
health data surveillance and analytics infrastructure modernization, 
disseminating information about testing, and workforce support 
necessary to expand and improve COVID–19 testing: Provided fur-
ther, That of the amount appropriated under this paragraph in
H. R. 266—6 
this Act, not less than $306,000,000 shall be transferred to the 
‘‘National Institutes of Health—National Cancer Institute’’ to 
develop, validate, improve, and implement serological testing and 
associated technologies for the purposes specified under this para-
graph in this Act: Provided further, That of the amount appropriated 
under this paragraph in this Act, not less than $500,000,000 shall 
be transferred to the ‘‘National Institutes of Health—National 
Institute of Biomedical Imaging and Bioengineering’’ to accelerate 
research, development, and implementation of point of care and 
other rapid testing related to coronavirus: Provided further, That 
of the amount appropriated under this paragraph in this Act, not 
less than $1,000,000,000 shall be transferred to the ‘‘National 
Institutes of Health—Office of the Director’’ to develop, validate, 
improve, and implement testing and associated technologies; to 
accelerate research, development, and implementation of point of 
care and other rapid testing; and for partnerships with govern-
mental and non-governmental entities to research, develop, and 
implement the activities outlined in this proviso: Provided further, 
That funds in the preceding proviso may be transferred to the 
accounts of the Institutes and Centers of the National Institutes 
of Health (referred to in this paragraph as the ‘‘NIH’’) for the 
purposes specified in the preceding proviso: Provided further, That 
the transfer authority provided in the preceding proviso is in addi-
tion to all other transfer authority available to the NIH: Provided 
further, That of the amount appropriated under this paragraph 
in this Act, not less than $1,000,000,000 shall be available to 
the Biomedical Advanced Research and Development Authority for 
necessary expenses of advanced research, development, manufac-
turing, production, and purchase of diagnostic, serologic, or other 
COVID–19 tests or related supplies, and other activities related 
to COVID–19 testing at the discretion of the Secretary: Provided 
further, That of the amount appropriated under this paragraph 
in this Act, $22,000,000, shall be transferred to the ‘‘Department 
of Health and Human Services—Food and Drug Administration— 
Salaries and Expenses’’ to support activities associated with diag-
nostic, serological, antigen, and other tests, and related administra-
tive activities: Provided further, That the amount appropriated 
under this paragraph in this Act may be used for grants for the 
rent, lease, purchase, acquisition, construction, alteration, renova-
tion, or equipping of non-federally owned facilities to improve 
preparedness and response capability at the State and local level 
for diagnostic, serologic, or other COVID–19 tests, or related sup-
plies: Provided further, That the amount appropriated under this 
paragraph in this Act may be used for construction, alteration, 
renovation, or equipping of non-federally owned facilities for the 
production of diagnostic, serologic, or other COVID–19 tests, or 
related supplies, where the Secretary determines that such a con-
tract is necessary to secure, or for the production of, sufficient 
amounts of such tests or related supplies: Provided further, That 
funds appropriated under this paragraph in this Act may be used 
for purchase of medical supplies and equipment, including personal 
protective equipment and testing supplies to be used for admin-
istering tests, increased workforce and trainings, emergency oper-
ation centers, and surge capacity for diagnostic, serologic, or other 
COVID–19 tests, or related supplies: Provided further, That prod-
ucts purchased with funds appropriated under this paragraph in 
this Act may, at the discretion of the Secretary, be deposited in
H. R. 266—7 
the Strategic National Stockpile under section 319F–2 of the Public 
Health Service Act: Provided further, That of the amount appro-
priated under this paragraph in this Act, $600,000,000 shall be 
transferred to ‘‘Health Resources and Services Administration— 
Primary Health Care’’ for grants under the Health Centers program, 
as defined by section 330 of the Public Health Service Act, and 
for grants to federally qualified health centers, as defined in section 
1861(aa)(4)(B) of the Social Security Act: Provided further, That 
sections 330(e)(6)(A)(iii), 330(e)(6)(B)(iii), and 330(r)(2)(B) of the 
Public Health Service Act shall not apply to funds provided under 
the previous proviso: Provided further, That of the amount appro-
priated under this paragraph in this Act, $225,000,000 shall be 
used to provide additional funding for COVID–19 testing and 
related expenses, through grants or other mechanisms, to rural 
health clinics as defined in section 1861(aa)(2) of the Social Security 
Act, with such funds also available to such entities for building 
or construction of temporary structures, leasing of properties, and 
retrofitting facilities as necessary to support COVID–19 testing: 
Provided further, That such funds shall be distributed using the 
procedures developed for the Provider Relief Fund authorized under 
the third paragraph under this heading in division B of the 
Coronavirus Aid, Relief, and Economic Security Act (Public Law 
116–136); may be distributed using contracts or agreements estab-
lished for such program; and shall be subject to the process require-
ments applicable to such program: Provided further, That the Sec-
retary may specify a minimum amount for each eligible entity 
accepting assistance under the two previous provisos: Provided 
further, That up to $1,000,000,000 of funds provided under this 
paragraph in this Act may be used to cover the cost of testing 
for the uninsured, using the definitions applicable to funds provided 
under this heading in Public Law 116–127: Provided further, That 
not later than 21 days after the date of enactment of this Act, 
the Secretary, in coordination with other appropriate departments 
and agencies, shall issue a report on COVID–19 testing: Provided 
further, That such report shall include data on demographic 
characteristics, including, in a de-identified and disaggregated 
manner, race, ethnicity, age, sex, geographic region and other rel-
evant factors of individuals tested for or diagnosed with COVID– 
19, to the extent such information is available: Provided further, 
That such report shall include information on the number and 
rates of cases, hospitalizations, and deaths as a result of COVID– 
19: Provided further, That such report shall be submitted to the 
Committees on Appropriations of the House and Senate, and the 
Committee on Energy and Commerce of the House of Representa-
tives and the Committee on Health, Education, Labor, and Pensions 
of the Senate, and updated and resubmitted to such Committees, 
as necessary, every 30 days until the end of the COVID–19 public 
health emergency first declared by the Secretary on January 31, 
2020: Provided further, That not later than 180 days after the 
date of enactment of this Act, the Secretary shall issue a report 
on the number of positive diagnoses, hospitalizations, and deaths 
as a result of COVID–19, disaggregated nationally by race, eth-
nicity, age, sex, geographic region, and other relevant factors: Pro-
vided further, That such report shall include epidemiological anal-
ysis of such data: Provided further, That not later than 30 days 
after the date of the enactment of this Act, the Secretary, in 
coordination with other departments and agencies, as appropriate,
H. R. 266—8 
shall report to the Committees on Appropriations of the House 
and Senate, the Committee on Energy and Commerce of the House 
of Representatives, and the Committee on Health, Education, Labor, 
and Pensions of the Senate on a COVID–19 strategic testing plan: 
Provided further, That such plan shall assist States, localities, 
territories, tribes, tribal organizations, and urban Indian health 
organizations, in understanding COVID–19 testing for both active 
infection and prior exposure, including hospital-based testing, high- 
complexity laboratory testing, point-of-care testing, mobile-testing 
units, testing for employers and other settings, and other tests 
as necessary: Provided further, That such plan shall include esti-
mates of testing production that account for new and emerging 
technologies, as well as guidelines for testing: Provided further, 
That such plan shall address how the Secretary will increase 
domestic testing capacity, including testing supplies; and address 
disparities in all communities: Provided further, That such plan 
shall outline Federal resources that are available to support the 
testing plans of each State, locality, territory, tribe, tribal organiza-
tion, and urban Indian health organization: Provided further, That 
such plan shall be updated every 90 days until funds are expended: 
Provided further, That such amount is designated by the Congress 
as being for an emergency requirement pursuant to section 
251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Con-
trol Act of 1985. 
GENERAL PROVISIONS—THIS TITLE 
(INCLUDING TRANSFER OF FUNDS) 
SEC. 101. The requirements, authorities, and conditions 
described in sections 18108, 18109, and 18112 of division B of 
the Coronavirus Aid, Relief, and Economic Security Act (Public 
Law 116–136) shall apply to funds appropriated in this Act to 
the Department of Health and Human Services. 
SEC. 102. Funds appropriated by this Act under the heading 
‘‘Department of Health and Human Services’’, except for the 
amounts specified in the first paragraph and the first and second 
provisos in the second paragraph under the heading ‘‘Public Health 
and Social Services Emergency Fund’’, may be transferred to, and 
merged with, other appropriation accounts under the headings ‘‘Cen-
ters for Disease Control and Prevention’’, ‘‘Public Health and Social 
Services Emergency Fund’’, ‘‘Food and Drug Administration’’, and 
‘‘National Institutes of Health’’ to prevent, prepare for, and respond 
to coronavirus following consultation with the Office of Management 
and Budget: Provided, That the Committees on Appropriations of 
the House of Representatives and the Senate shall be notified 
10 days in advance of any such transfer: Provided further, That, 
upon a determination that all or part of the funds transferred 
from an appropriation by this Act are not necessary, such amounts 
may be transferred back to that appropriation: Provided further, 
That none of the funds made available by this Act may be trans-
ferred pursuant to the authority in section 205 of division A of 
Public Law 116–94 or section 241(a) of the Public Health Service 
Act. 
SEC. 103. Of the funds appropriated by this Act under the 
heading ‘‘Public Health and Social Services Emergency Fund’’, up 
to $6,000,000 shall be transferred to, and merged with, funds made
H. R. 266—9 
available under the heading ‘‘Office of the Secretary, Office of 
Inspector General’’, and shall remain available until expended, for 
oversight of activities supported with funds appropriated to the 
Department of Health and Human Services to prevent, prepare 
for, and respond to coronavirus, domestically or internationally: 
Provided, That the Inspector General of the Department of Health 
and Human Services shall consult with the Committees on Appro-
priations of the House of Representatives and the Senate prior 
to obligating such funds: Provided further, That the transfer 
authority provided by this section is in addition to any other transfer 
authority provided by law. 
TITLE II 
INDEPENDENT AGENCIES 
SMALL BUSINESS ADMINISTRATION 
SALARIES AND EXPENSES 
For an additional amount for ‘‘Salaries and Expenses’’, 
$2,100,000,000, to remain available until September 30, 2021, to 
prevent, prepare for, and respond to coronavirus, domestically or 
internationally: Provided, That such amount is designated by the 
Congress as being for an emergency requirement pursuant to section 
251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Con-
trol Act of 1985. 
DISASTER LOANS PROGRAM ACCOUNT 
For an additional amount for ‘‘Disaster Loans Program Account’’ 
for the cost of direct loans authorized by section 7(b) of the Small 
Business Act, $50,000,000,000, to remain available until expended, 
to prevent, prepare for, and respond to coronavirus, domestically 
or internationally: Provided, That such amount is designated by 
the Congress as being for an emergency requirement pursuant 
to section 251(b)(2)(A)(i) of the Balanced Budget and Emergency 
Deficit Control Act of 1985. 
EMERGENCY EIDL GRANTS 
For an additional amount for ‘‘Emergency EIDL Grants’’ for 
the cost of emergency EIDL grants authorized by section 1110 
of division A of the CARES Act (Public Law 116–136), 
$10,000,000,000, to remain available until expended, to prevent, 
prepare for, and respond to coronavirus, domestically or internation-
ally: Provided, That such amount is designated by the Congress 
as being for an emergency requirement pursuant to section 
251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Con-
trol Act of 1985. 
TITLE III 
GENERAL PROVISIONS—THIS ACT 
SEC. 301. Each amount appropriated or made available by 
this Act is in addition to amounts otherwise appropriated for the 
fiscal year involved.
H. R. 266—10 
SEC. 302. No part of any appropriation contained in this Act 
shall remain available for obligation beyond the current fiscal year 
unless expressly so provided herein. 
SEC. 303. Unless otherwise provided for by this Act, the addi-
tional amounts appropriated by this Act to appropriations accounts 
shall be available under the authorities and conditions applicable 
to such appropriations accounts for fiscal year 2020. 
SEC. 304. Notwithstanding any other provision of law, funds 
made available in this Act, or transferred pursuant to authorization 
granted in this Act, may only be used to prevent, prepare for, 
and respond to coronavirus. 
SEC. 305. In this Act, the term ‘‘coronavirus’’ means SARS– 
CoV–2 or another coronavirus with pandemic potential. 
SEC. 306. Each amount designated in this Act by the Congress 
as being for an emergency requirement pursuant to section 
251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Con-
trol Act of 1985 shall be available (or rescinded or transferred, 
if applicable) only if the President subsequently so designates all 
such amounts and transmits such designations to the Congress. 
SEC. 307. Any amount appropriated by this Act, designated 
by the Congress as an emergency requirement pursuant to section 
251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Con-
trol Act of 1985 and subsequently so designated by the President, 
and transferred pursuant to transfer authorities provided by this 
Act shall retain such designation. 
BUDGETARY EFFECTS 
SEC. 308. (a) STATUTORY PAYGO SCORECARDS.—The budgetary 
effects of this division shall not be entered on either PAYGO score-
card maintained pursuant to section 4(d) of the Statutory Pay 
As-You-Go Act of 2010. 
(b) SENATE PAYGO SCORECARDS.—The budgetary effects of this 
division shall not be entered on any PAYGO scorecard maintained 
for purposes of section 4106 of H. Con. Res. 71 (115th Congress). 
(c) CLASSIFICATION OF BUDGETARY EFFECTS.—Notwithstanding 
Rule 3 of the Budget Scorekeeping Guidelines set forth in the 
joint explanatory statement of the committee of conference accom-
panying Conference Report 105–217 and section 250(c)(7) and (c)(8) 
of the Balanced Budget and Emergency Deficit Control Act of 1985, 
the budgetary effects of this division shall be estimated for purposes 
of section 251 of such Act.